Gut Microbiota and ADHD: Direct Links
In 2026, scientists from the Institute of Neuroscience of the Russian Academy of Sciences confirmed that an imbalance in gut microbiota directly affects the symptoms of attention-deficit/hyperactivity disorder (ADHD) in children.
The findings were published in the journal Pediatric Science and are among the first to confirm biochemical mechanisms linking the gut microbiome to neurobehavioral symptoms. The discovery has important implications for developing new therapeutic strategies.
How Microbiota Affect the Brain
The scientists used metabolomics and microbial DNA sequencing, establishing a correlation between lower levels of Bifidobacterium and poorer attention and self-control.
Dopamine plays a key role in regulating attention and motivation, and dopamine deficiency is closely associated with ADHD symptoms. A decline in bacteria involved in synthesizing dopamine precursors may worsen neurological disorders, supporting the hypothesis that the microbiome may be a contributing cause in some cases of ADHD.
Clinical and Therapeutic Prospects
The study used probiotic therapy with the Bifidobacterium longum strain, which reduced hyperactivity symptoms by 20% after 8 weeks of use. This opens up the possibility of using specialized probiotics as part of a comprehensive treatment plan for children with ADHD.
In addition, doctors at St. Petersburg Children’s Clinical Hospital No. 1 note that correcting the microbiota may reduce the need for medication, which is important for minimizing side effects and improving patients’ quality of life.
What This Means for Parents and Educators
For parents of children with ADHD, the study highlights the importance of monitoring diet and gut health. A diet rich in prebiotics and probiotics, along with timely medical assessment of the microbiota, may become part of prevention and support for the child.
Educators who work with children with ADHD can consider possible biological causes of attention and behavioral difficulties, helping them develop more effective educational and intervention programs tailored to each child’s individual needs.
Further Research and Challenges
Despite these advances, the scientists emphasize the need for large-scale clinical trials to confirm the effectiveness of microbiome interventions across different age groups. An international project involving more than 500 children from Russia, Europe, and Asia is scheduled to begin in 2026 to study the long-term effects of probiotics.
Meanwhile, standards for diagnosing the microbiota in children with neurological disorders are being developed. These will make it possible to integrate such methods into the everyday practice of pediatricians and neurologists, improving the accuracy and personalization of ADHD treatment.
Conclusion: Research in 2026 is opening new horizons for understanding and treating ADHD by correcting gut microbiota, potentially improving children’s quality of life significantly.